BOSTON PHARMACEUTICALS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 21 Mar 2025)
What this means for you
Registered since 22 Oct 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87728436
- Registration number
- 5888033
- Mark type
- Design + words
- Filed
- 20 Dec 2017
- Published for opposition
- 06 Aug 2019
- Registered
- 22 Oct 2019
- Attorney of record
- Camille M. Miller
Goods and services
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Owner
- Boston Pharmaceuticals, Inc., Cambridge, MA, US
- Boston Pharmaceuticals, Inc., Cambridge, MA, US
- Boston Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 21 Mar 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 21 Mar 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 21 Mar 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Nov 2024 — TEAS SECTION 8 & 15 RECEIVED
- 22 Oct 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 01 Oct 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Oct 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 01 Oct 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 01 Oct 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 01 Oct 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 22 Oct 2019 — REGISTERED-PRINCIPAL REGISTER
- 06 Aug 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Aug 2019 — PUBLISHED FOR OPPOSITION
- 17 Jul 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Jun 2019 — TEAS CHANGE OF CORRESPONDENCE RECEIVED